Patterson Companies | Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.79B 254M 2025-09
Align Technology USD 1B 103.43M 2025-09
Bruker USD 293.1M 201.1M 2025-09
Cardinal Health USD 2.78B 1.82B 2025-12
Charles River Laboratories USD 213.77M 6.67M 2025-12
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
Cooper Companies USD 124.9M 13.3M 2025-06
CVS Health USD 8.45B 645M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 363M 4M 2025-09
eHealth USD 63.09M 2.83M 2025-09
Henry Schein USD 136M 9M 2025-09
Idexx Laboratories USD 180.07M 28.1M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
McKesson USD 2.96B 1.05B 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Owens Minor USD 32.84M 5.42M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Quest Diagnostics USD 420M 12M 2025-12
Repligen USD 748.75M 39.89M 2025-09
Revvity USD 919.86M 11.53M 2025-12
Stryker USD 4.01B 755M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 587.83M 128.71M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12
Zoetis USD 2.08B 649M 2025-09


Patterson Companies Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.